Shah established and leads QPharma’s thought leader engagement practice, and his approach to achieving effective medical communication and optimizing the pharma field sales force has been well received by the industry. In this expanded role, he will take on enhanced responsibilities for growth and business development in QPharma’s KOL engagement and healthcare practitioner (HCP) targeting business. He will also lead efforts to establish and grow the practices in Europe, Asia, and Latin America.
“Since joining the company, Badal has helped shape QPharma’s status as a leader in the KOL engagement and HCP targeting space,” said Patrick P. Den Boer, President and CEO. “In this new role, he will continue to develop solutions that greatly enhance the commercial success of our life sciences clients.”
A pharmacist and Rutgers University science and business graduate, with a specialization in Drug Discovery and Development, Shah is a member of the Advisory Board of Directors for the American Pharmacy Purchasing Alliance. He is based at QPharma’s Morristown, New Jersey headquarters.